Luigi Gnudi
Luigi Gnudi is an expert in Endocrinology at British Heart Foundation (United Kingdom). As of October 2026, ScienceLeadR ranks Luigi Gnudi in the top 1% of experts worldwide for Diabetic Nephropathies, Diabetes Mellitus and Glucose Metabolism Disorders. Luigi Gnudi has authored 162 publications, the most recent in 2026, and is an investigator in 9 clinical trials. SLR score: 520 (community average: 125). How the SLR is computed.
LeadR Profile
Endocrinology
Subspecialties: Nephrology - Cardiology - Biochemistry
Main Topics
Publications and Clinical Studies
Profile data updated on
Expert Rankings
Top experts on the MeSH terms this expert works on
Organizations
Career arc: 1995 - 2026
Number : 162
Citations
Main journals
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
| Title | Journal | Year | Citations |
|---|---|---|---|
| The effects of ursodeoxycholic acid on albuminuria in people with type 1 diabetes and diabetic kidney disease: a proof-of-concept study. PMID 42857346 — diabetes mellitus, kidney diseases, ursodeoxycholic acid, diabetic nephropathies, albuminuria, kidney, proof of concept study, therapeutics, diabetes mellitus, type 1 | Front Endocrinol (Lausanne) | 2026 | 0 |
| The role of sex and ethnicity in the variability of estimated glomerular filtration rate (eGFR) in people with type 1 diabetes. PMID 42675625 — diabetes mellitus, kidney diseases, glomerular filtration rate, sex, diabetes mellitus, type 1 | Diabet Med | 2026 | 0 |
| Ultrasound-guided renal artery administration of angiopoietin-1 RNA therapy slows the progression of preclinical WT1 glomerular disease. PMID 42585291 — genes, wilms tumor, podocytes, kidney, arteries, wilms tumor, angiopoietin-1, angiopoietins, therapeutics, mutation, child, renal artery | Sci Transl Med | 2026 | 0 |
| Effect of lixisenatide on arterial stiffness in people with type 2 diabetes and kidney disease: Results of a randomised controlled trial. PMID 41705420 — diabetes mellitus, kidney diseases, glucagon-like peptide 1, diabetic nephropathies, kidney, therapeutics, diabetes mellitus, type 2 | Diabetes Obes Metab | 2026 | 0 |
| The expanding role of Nogo-B in hypertension: linking kidney physiology, endothelial function and inflammation. PMID 41537371 — hypertension, physiology, blood, epithelial sodium channels, blood pressure, kidney, endoplasmic reticulum, therapeutics, lipopolysaccharides, nitric oxide synthase type iii | J Hypertens | 2026 | 0 |
Clinical Studies 9
Synthesis
By phase:
By status:
By type:
By Monocentric/Multicentric:
LeadR Networks
Main global connection map